RECRUITING

Multimedia Aid for Genetic Testing in Gynecologic Oncology

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This pilot study aims to estimate rates of genetic testing in patients with ovarian and endometrial cancer before and after the implementation of educational videos about genetic testing. Subjects will be asked to view one of three videos relevant to their cancer diagnosis and genetic testing, and have the option to complete a brief satisfaction survey. A chart review to evaluate rates of genetic testing ordered and referrals placed to Genetics before and after the implementation of the videos will be conducted. Up to 15-20% of ovarian cancer and 3-5% of endometrial cancer is due to inherited genetic mutation. Given this association, the National Comprehensive Cancer Network (NCCN) recommends genetic counseling and testing for all individuals with a diagnosis of ovarian cancer and endometrial cancer. Some challenges to obtaining genetic counseling and testing include missed identification and referral of eligible patients by providers, lack of provider knowledge, and busy clinic visits limiting time for informed consent and maintaining patient autonomy for genetic testing. Although heterogeneous, the literature supports multimedia use in cancer genetics. However, there is a paucity of data in the field of gynecologic oncology for the role of integrating a multimedia approach to genetic counseling.

Official Title

Multimedia Aid for Genetic Testing in Gynecologic Oncology

Quick Facts

Study Start:2024-10-10
Study Completion:2025-10-10
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT07084168

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:FEMALE
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Reviewed informed consent to participate in the study.
  2. * Subject is willing and able to comply with study procedures based on the judgment of the investigator.
  3. * Age ≥ 18 years at the time of consent.
  4. * Diagnosis of ovarian cancer or endometrial cancer
  5. * Eligible for genetic testing
  6. * English or Spanish is the primary language
  1. * Previously completed genetic testing
  2. * Did not receive initial cancer-directed treatment at study site

Contacts and Locations

Study Contact

Luz Cuaboy
CONTACT
919-843-5400
luz_cuaboy@med.unc.edu

Principal Investigator

Katherine Tucker, MD
PRINCIPAL_INVESTIGATOR
UNC Lineberger Comprehensive Cancer Center

Study Locations (Sites)

Univeristy of North Carolina at Chapel Hill
Chapel Hill, North Carolina, 27599
United States

Collaborators and Investigators

Sponsor: UNC Lineberger Comprehensive Cancer Center

  • Katherine Tucker, MD, PRINCIPAL_INVESTIGATOR, UNC Lineberger Comprehensive Cancer Center

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-10-10
Study Completion Date2025-10-10

Study Record Updates

Study Start Date2024-10-10
Study Completion Date2025-10-10

Terms related to this study

Keywords Provided by Researchers

  • genetic testing
  • video implementation
  • chart review

Additional Relevant MeSH Terms

  • Ovary Cancer
  • Endometrial Cancer